Title:
COMPOSITIONS AND METHODS FOR DECREASING INFLAMMATION
Document Type and Number:
WIPO Patent Application WO/2022/036229
Kind Code:
A3
Abstract:
The present invention features bifunctional, soluble ecto-enzymes that are engineered to hydrolyze extracellular nucleotide triphosphates (e.g., ATP) to a nucleoside (e.g., adenosine), through the fusion of the ectodomains (ECD) of an ecto-nucleoside triphosphate diphosphohydrolase (E- NTPDase) and a nucleotide monophosphatase (NMPAse), such as an ecto-5' nucleotidase (eN), alkaline phosphatase (ALP), or an acid phosphatase (AP). Also described are methods of use thereof, e.g. for limiting and decreasing inflammation and sequelae.
More Like This:
Inventors:
ROBSON SIMON (US)
ZHONG ELIZABETH (US)
ZHONG ELIZABETH (US)
Application Number:
PCT/US2021/045956
Publication Date:
April 21, 2022
Filing Date:
August 13, 2021
Export Citation:
Assignee:
BETH ISRAEL DEACONESS MEDICAL CT INC (US)
International Classes:
C12N9/14; A61K38/46; C12N9/16
Foreign References:
US20150190481A1 | 2015-07-09 | |||
US20050037382A1 | 2005-02-17 |
Attorney, Agent or Firm:
ARMSTRONG, Richard, Todd (US)
Download PDF:
Previous Patent: SIMPLIFIED ARCHITECTURE FOR DESALINATION VIA ELECTRODIALYSIS
Next Patent: SLIDING CAM FOLLOWER
Next Patent: SLIDING CAM FOLLOWER